Abstract:The rise of antibiotic-resistant pathogens and the widespread occurrence of inflammatory diseases have raised considerable global health concerns. Consequently, there is a critical need to formulate novel and potent drug candidates to counteract these pressing global threats effectively. Hence, this study presents a comprehensive investigation involving spectral (FT-IR, and 1H NMR) analysis, experimental, molecular docking, and quantum chemical calculations employing density functional theory (DFT) to fully characterize and identify the synthesized compounds (Thiosemicarbazide Schiff base (TSB), 4‑methoxy aniline Schiff base (ASB), Phenyl urea Schiff base (PSB) at the ωB97XD/6-311++G(2d,2p) level of theory. Noteworthy observations from the antimicrobial investigations against four different microorganisms: Staphylococcus aureus, Escherichia coli, Candida albicans, and Aspergillus niger, TSB and ASB displayed varying degrees of antimicrobial activity. Notably, they exhibited the most significant effect against Candida albicans and A. niger, showing promise in combatting fungal infections. In contrast, PSB demonstrated moderate to high antimicrobial activity against E. coli, ranging from 15 mm to 24 mm. Molecular docking studies further confirmed TSB's strong binding affinity against Candida albicans with -6.4 kcal/mol, indicating robust interaction with the target protein. TSB also exhibited reasonably good binding affinities of -5.5 kcal/mol and -5.1 kcal/mol against Aspergillus niger and E. coli, respectively. ASB and PSB displayed particularly strong binding affinities against specific microorganisms, making them potential candidates for further investigation as antimicrobial agents. Furthermore, investigation into anti-inflammatory activity revealed that PSB demonstrated the highest free radical scavenging activity, with a percentage of 62.39 % and an IC50 value of 41.83. ASB followed with a free radical scavenging activity of 58.71 % and an IC50 value of 67.62, while TSB exhibited a free radical scavenging activity of 57.79 % with an IC50 value of 72. These findings were consistent with molecular docking analysis, suggesting that TSB effectively interacts with the active sites of the target proteins, potentially modulating the inflammatory response. Interestingly, PSB showed superior free radical scavenging activity compared to ASB and TSB, indicating its potential as an effective anti-inflammatory agent.

Spectroscopic, electrochemical DNA binding and in vivo anti-inflammatory studies on newly synthesized Schiff bases of 4-aminophenazone

Design, synthesis, and biological evaluation of novel carbazole aminothiazoles as potential DNA-targeting antimicrobial agents

Medicinal Studies of Dimeric Phenols with Multiple Quaternary‐Ammonium Pendant Arms

Synthesis and Study of the Biological Activity of New Compounds Derived from 4-(5-Phenyl-1,3,4-oxadiazole-2-yl)aniline

Synthesis, Spectral Identification of Some New Schiff Bases, and Evaluation of Their Antibacterial Activity and Inhibitory Effect on Proinflammatory Cytokines (IL-1β, TNF), and DNA Ligase

Evaluation of in vitro antibacterial, DNA binding, DNA damage, DFT and antioxidant studies of aminobenzaldehyde-based heterocyclic Schiff base derivatives

Newly synthesized sulfonamide derivatives explored for DNA binding, enzyme inhibitory, and cytotoxicity activities: a mixed computational and experimental analyses

Synthesis, Characterization, Investigation of DNA Interactions and Biological Evaluation of Co(II), Ni(II), Cu(II) and Zn(II) Complexes with Newly Synthesized 2-methoxy 5-trifluoromethyl benzenamine Schiff Base

Synthesis and Characterization of Zn(II) Complex of 4-chloro-2-(((2-phenoxyphenyl)imino)methyl)phenol and its Biological Efficacies: DNA Interaction, ADMET, DFT and Molecular Docking Study

Synthesis, biological and molecular docking studies of pyrimidine-derived bioactive Schiff bases

Synthesis, DNA binding, cellular DNA lesion and cytotoxicity of a series of new benzimidazole-based Schiff base copper(II) complexes

Investigation on synthesized sulfonamide Schiff base with DFT approaches and in silico pharmacokinetic studies: Topological, NBO, and NLO analyses

Biological Activities, DFT and Molecular Docking Studies of Novel Schiff Bases Derived from Sulfamethoxypyridazine

Synthesis, Structural Elucidation, and Biological Potential of Novel Sulfonamide Drugs

Investigations into the anti-inflammatory and anti-diabetic activity of newly synthesized derivatives of 4AP2BOB utilizing DFT, molecular docking and spectroscopic characterization

Synthesis, characterization, antibacterial activity, DFT and molecular docking studies of four 4- phenyldiazenyl phenyl aminophosphonates

Synthesis, characterisation, and in vitro antiparasitic activity of new flavanoidal tetrazinan-6'-ones and their binding study with calf thymus DNA using molecular modelling and spectroscopic techniques

In vitro and in vivo evaluation of the antimicrobial, antioxidant, cytotoxic, hemolytic activities and in silico POM/DFT/DNA-binding and pharmacokinetic analyses of new sulfonamide bearing thiazolidin-4-ones

Synthesis, spectroscopic characterization and in vitro antimicrobial, anticancer and antileishmanial activities as well interaction with Salmon sperm DNA of newly synthesized carboxylic acid derivative, 4-(4-methoxy-2-nitrophenylamino)-4-oxobutanoic acid

Investigating the antimicrobial and anti-inflammatory activities of novel thiophene derivatives by in-vitro studies, molecular docking, spectral analysis, and quantum chemical calculations

Synthesis, characterization, docking studies and anti-inflammatory activity of new safe NSAIDs agent based on Ibuprofen phenylalanine derivatives